Smith Group Asset Management’s AngioDynamics ANGO Stock Holding History

Smith Group Asset Management’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-10,251	Closed	-$107K	–	303
2020 Q1	$107K	Hold	10,251	–	–	0.01%	209
2019 Q4	$164K	Hold	10,251	–	–	0.01%	211
2019 Q3	$189K	Hold	10,251	–	–	0.01%	192
2019 Q2	$202K	Hold	10,251	–	–	0.01%	202
2019 Q1	$234K	Sell	10,251 -620	-6%	-$13.5K	0.01%	209
2018 Q4	$219K	Hold	10,871	–	–	0.01%	235
2018 Q3	$236K	Hold	10,871	–	–	0.01%	240
2018 Q2	$242K	Hold	10,871	–	–	0.01%	239
2018 Q1	$188K	Sell	10,871 -379	-3%	-$6.32K	0.01%	257
2017 Q4	$187K	Hold	11,250	–	–	0.01%	259
2017 Q3	$192K	Sell	11,250 -820	-7%	-$13.8K	0.01%	269
2017 Q2	$196K	Sell	12,070 -5,500	-31%	-$87K	0.01%	271
2017 Q1	$305K	Hold	17,570	–	–	0.01%	226
2016 Q4	$296K	Buy	+17,570	New	+$293K	0.01%	224

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Smith Group Asset Management's ANGO Position: Q2 2020 in Review

Smith Group Asset Management sold out of AngioDynamics (ANGO) in Q2 2020, closing a stake of 10,251 shares — an estimated $107K sold.

Smith Group Asset Management first reported a position in ANGO in Q4 2016 and held it in 14 quarters. The position peaked at $305K in Q1 2017. 146 funds tracked by Wall St. Rank hold ANGO as of Q2 2020.

Smith Group Asset Management reported no remaining AngioDynamics position as of Q2 2020 after selling out during the quarter.
Smith Group Asset Management sold 10,251 AngioDynamics shares in Q2 2020, an estimated $107K.
Smith Group Asset Management first reported a position in AngioDynamics in Q4 2016 and held it in 14 quarters.
Smith Group Asset Management's AngioDynamics position peaked at $305K in Q1 2017.
146 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2020.

Based on Smith Group Asset Management's 13F filing for Q2 2020, filed 6 Aug 2020.